Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
240359 | Procedia Chemistry | 2015 | 9 Pages |
Abstract
The non-mevalonate (methylerythritol phosphate, MEP) pathway for isoprenoid biosynthesis is essential in Plasmodium spp.., but is absent in the human host. The pathway is a clinically validated antimalarial target on basis of studies with the antibiotic fosmidomycin, an inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr, IspC), which catalyses the first committed step of the MEP-pathway. In this review, we report on reverse, hydroxamate-based fosmidomycin analogues, which are studied by enzyme kinetics, parasite growth inhibition and crystallography in order to identify compounds with enhanced antiplasmodial activity.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Chemical Engineering (General)